224 related articles for article (PubMed ID: 11507088)
21. Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus.
Galigniana MD; Harrell JM; O'Hagen HM; Ljungman M; Pratt WB
J Biol Chem; 2004 May; 279(21):22483-9. PubMed ID: 15004035
[TBL] [Abstract][Full Text] [Related]
22. Contribution of two independent MDM2-binding domains in p14(ARF) to p53 stabilization.
Lohrum MA; Ashcroft M; Kubbutat MH; Vousden KH
Curr Biol; 2000 May; 10(9):539-42. PubMed ID: 10801444
[TBL] [Abstract][Full Text] [Related]
23. p53-independent association between SV40 large T antigen and the major cytosolic heat shock protein, HSP90.
Miyata Y; Yahara I
Oncogene; 2000 Mar; 19(11):1477-84. PubMed ID: 10723140
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins.
Shimamura T; Lowell AM; Engelman JA; Shapiro GI
Cancer Res; 2005 Jul; 65(14):6401-8. PubMed ID: 16024644
[TBL] [Abstract][Full Text] [Related]
25. Design of novel Geldanamycin analogue hsp90 alpha-inhibitor in silico for breast cancer therapy.
Mahanta S; Pilla S; Paul S
Med Hypotheses; 2013 Sep; 81(3):463-9. PubMed ID: 23860250
[TBL] [Abstract][Full Text] [Related]
26. Nuclear exclusion of p53 in a subset of tumors requires MDM2 function.
Lu W; Pochampally R; Chen L; Traidej M; Wang Y; Chen J
Oncogene; 2000 Jan; 19(2):232-40. PubMed ID: 10645001
[TBL] [Abstract][Full Text] [Related]
27. Analysis of JNK, Mdm2 and p14(ARF) contribution to the regulation of mutant p53 stability.
Buschmann T; Minamoto T; Wagle N; Fuchs SY; Adler V; Mai M; Ronai Z
J Mol Biol; 2000 Jan; 295(4):1009-21. PubMed ID: 10656807
[TBL] [Abstract][Full Text] [Related]
28. AQP2 Abundance is Regulated by the E3-Ligase CHIP Via HSP70.
Centrone M; Ranieri M; Di Mise A; Berlingerio SP; Russo A; Deen PMT; Staub O; Valenti G; Tamma G
Cell Physiol Biochem; 2017; 44(2):515-531. PubMed ID: 29145196
[TBL] [Abstract][Full Text] [Related]
29. ErbB2 degradation mediated by the co-chaperone protein CHIP.
Zhou P; Fernandes N; Dodge IL; Reddi AL; Rao N; Safran H; DiPetrillo TA; Wazer DE; Band V; Band H
J Biol Chem; 2003 Apr; 278(16):13829-37. PubMed ID: 12574167
[TBL] [Abstract][Full Text] [Related]
30. CAIR-1/BAG-3 abrogates heat shock protein-70 chaperone complex-mediated protein degradation: accumulation of poly-ubiquitinated Hsp90 client proteins.
Doong H; Rizzo K; Fang S; Kulpa V; Weissman AM; Kohn EC
J Biol Chem; 2003 Aug; 278(31):28490-500. PubMed ID: 12750378
[TBL] [Abstract][Full Text] [Related]
31. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.
Wang C; Ivanov A; Chen L; Fredericks WJ; Seto E; Rauscher FJ; Chen J
EMBO J; 2005 Sep; 24(18):3279-90. PubMed ID: 16107876
[TBL] [Abstract][Full Text] [Related]
32. Repression of hsp90beta gene by p53 in UV irradiation-induced apoptosis of Jurkat cells.
Zhang Y; Wang JS; Chen LL; Zhang Y; Cheng XK; Heng FY; Wu NH; Shen YF
J Biol Chem; 2004 Oct; 279(41):42545-51. PubMed ID: 15284248
[TBL] [Abstract][Full Text] [Related]
33. Mdm2 binding to a conformationally sensitive domain on p53 can be modulated by RNA.
Burch LR; Midgley CA; Currie RA; Lane DP; Hupp TR
FEBS Lett; 2000 Apr; 472(1):93-8. PubMed ID: 10781812
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of Hsp90 inhibition on protein kinases regulating signal transduction pathways required for myoblast differentiation.
Yun BG; Matts RL
Exp Cell Res; 2005 Jul; 307(1):212-23. PubMed ID: 15922741
[TBL] [Abstract][Full Text] [Related]
35. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53.
Zhang Y; Xiong Y
Mol Cell; 1999 May; 3(5):579-91. PubMed ID: 10360174
[TBL] [Abstract][Full Text] [Related]
36. [Effect of HSP90 function inhibited on the telomerase and P53 mutant in breast cancer cells].
Li X; Deng HY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):181-3. PubMed ID: 18630678
[TBL] [Abstract][Full Text] [Related]
37. Oligomerization is required for p53 to be efficiently ubiquitinated by MDM2.
Maki CG
J Biol Chem; 1999 Jun; 274(23):16531-5. PubMed ID: 10347217
[TBL] [Abstract][Full Text] [Related]
38. SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.
Buschmann T; Fuchs SY; Lee CG; Pan ZQ; Ronai Z
Cell; 2000 Jun; 101(7):753-62. PubMed ID: 10892746
[TBL] [Abstract][Full Text] [Related]
39. MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation.
Jackson MW; Lindstrom MS; Berberich SJ
J Biol Chem; 2001 Jul; 276(27):25336-41. PubMed ID: 11297540
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanism of mutant p53 stabilization: the role of HSP70 and MDM2.
Wiech M; Olszewski MB; Tracz-Gaszewska Z; Wawrzynow B; Zylicz M; Zylicz A
PLoS One; 2012; 7(12):e51426. PubMed ID: 23251530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
